EU: EMEA to issue alcoholism treatment guidelines
The European Medicines Agency (EMEA) is to develop detailed guidance on the manufacture, market approval and use of drugs that can treat alcoholism, given that no such formal advice currently exists at a European Union (EU)-level.
The guidance will focus on clearly defining target patients, treatment success (whether drugs should end alcoholism, or also reduce drinking), and drug research project organisation.
The EMEA will also advise whether certain age groups should be excluded from such treatment, as well as patients suffering from other illnesses.
Existing treatments include Acamprosate, currently prescribed in the EU for preventing a recurrence of alcoholism, while other medicines are currently in development.
- Ten questions for Diageo - Analysis
- Have spirits companies forgotten the mainstream?
- How craft beer has shattered its US shackles
- Does alcohol accelerate the onset of dementia?
- Ashwagandha - The next functional drinks trend?
- Moet Hennessy unaffected by LVMH Dior buy
- BrewDog moves into spirits with LoneWolf launch
- Portman Group heads to Tesco for new chief exec
- William Grant names Europe & NA Travel Retail head
- Johnnie Walker Bourbon Cask & Rye Finish - NPD
- Global Scotch insights - market forecasts, product innovation and consumer trends
- Global Champagne and sparkling wine insights - market forecasts, product innovation and consumer trends
- Battle of the Generations - The fight for iGen, Millennial, Gen X and Baby Boomer consumers
- Craft Beer: Coming of Age or Past Its Prime?
- Myanmar - ISA Country Report